Zebra Capital Management LLC Veracyte, Inc. Transaction History

Zebra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $123,920 - $213,004	-3,762 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $945,743 - $1.73 Million	-21,267 Reduced 84.97%	3,762 $202,000
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $75,051 - $142,942	2,310 Added 10.17%	25,029 $1.23 Million
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $607,278 - $810,386	22,719 New	22,719 $738,000
Q2 2018 Aug 14, 2018	SELL	$5.39 - $9.66 $54,891 - $98,377	-10,184 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.44 - $6.97 $55,400 - $70,982	10,184 New	10,184 $57,000

260

82.4M

42.3K

18.2K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.51B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.